Chandra Panchal

Founder at Axcelon Biopolymers Corp.

Chandra Panchal

Chandra Panchal

Founder at Axcelon Biopolymers Corp.

Overview
Career Highlights

Mentra Nova Enterprises, Inc.
Rodocanachi Capital, Inc.
Axcelon Biopolymers Corp.

RelSci Relationships

361

Number of Boards

19

Birthday

1950

Age

71

Relationships
RelSci Relationships are individuals Chandra Panchal likely has professional access to. A relationship does not necessarily indicate a personal connection.

President & Chief Executive Officer at Medicenna Therapeutics Corp.

Relationship likelihood: Strong

Former President, Chief Executive Officer & Director at Alveda Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chief Executive Officer at CardioGenics Holdings, Inc.

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Ortho Regenerative Technologies, Inc.

Relationship likelihood: Strong

Member, Board of Directors at Axcelon Biopolymers Corp.

Relationship likelihood: Strong

Co-Owner at Hot Docs Ted Rogers Cinema

Relationship likelihood: Strong

Member, Board of Directors at CardioGenics, Inc.

Relationship likelihood: Strong

Chairman & Chief Executive Officer at ZBx Corp.

Relationship likelihood: Strong

Chairman & Chief Executive Officer at Canadian Oil Recovery & Remediation Enterprises Ltd.

Relationship likelihood: Strong

Member, Board of Directors at Axcelon Biopolymers Corp.

Relationship likelihood: Strong

Paths to Chandra Panchal
Potential Connections via
Relationship Science
You
Chandra Panchal
Founder at Axcelon Biopolymers Corp.
Education
Ph.D. in Biochemical Engineering
Class of 1979

The University of Western Ontario, which is commonly referred to among Canadian universities as Western, is a public research university located in London, Ontario, Canada. The university's main campus covers 455 hectares (1,120 acres) of land, with the Thames River running through the eastern portion. The university was founded on 7 March 1878 by Bishop Isaac Hellmuth of the Anglican Diocese of Huron as "The Western University of London Ontario." It incorporated Huron University College, which had been founded in 1863.

Graduate Degree
Class of 1974

Established in 1827, the University of Toronto has one of the strongest research and teaching faculties in North America, presenting top students at all levels with an intellectual environment unmatched in depth and breadth on any other Canadian campus. With more than 82,000* students across three campuses (St. George, Mississauga and Scarborough) and over 500,000 alumni active in every region of the world, U of T's influence is felt in every area of human endeavour.

Career History
Managing Director
2008 - Current

Panford Investment Corp.

Founder
2001 - Current

Axcelon Biopolymers Corp. provides medical devices for human health applications. It provides devices to those companies which uses nanotechnology to biodegradable polymer design and applications. Its technology includes stent coating, ophthalmology, drug delivery and regenerative medicine. The company is headquartered in Toronto, Canada

Adjunct Professor in Chemical & Biochemical Engineering
Current

The University of Western Ontario, which is commonly referred to among Canadian universities as Western, is a public research university located in London, Ontario, Canada. The university's main campus covers 455 hectares (1,120 acres) of land, with the Thames River running through the eastern portion. The university was founded on 7 March 1878 by Bishop Isaac Hellmuth of the Anglican Diocese of Huron as "The Western University of London Ontario." It incorporated Huron University College, which had been founded in 1863.

Boards & Committees
Director
1996 - Current
Director
Prior - 2009

JAG Media Holdings provides subscribers with investment news (called JagNotes) via its Web site and, to a lesser extent, fax. The site also offers some free information. The company has launched a division called The Company Voice, which offers public and investor relations services to public companies

Chairman, President & Chief Executive Officer
1989 - 2006

Procyon Biopharma, Inc. is a biopharmaceutical company engaged in the discovery and development of innovative cancer therapeutic, screening, and diagnostic products and technologies. Procyon has acquired four technologies of which two are broad platform technologies. These two are Prostate Secretory Protein (PSP94), for the prostate cancer market, and the ANA technology platform, that has been developed to improve the immune system and resistibility of cancer. The company is headquartered in Dorval in Québec, Canada

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Chandra Panchal. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Chandra Panchal's profile does not indicate a business or promotional relationship of any kind between RelSci and Chandra Panchal.